Analyst Consensus ?
ConsensusHold29 ratings
Bullish1137.9%
Neutral1655.2%
Bearish26.9%
FN2 Earnings Intelligence
Cintas Corporation analyst ratings
Cintas Corporation (CTAS) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$214.9Current
$23.44Low
$183.29Average
$250High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Sell | Sell | Maintain | Sep 30, 2026 |
| Argus Research | Buy | Buy | Maintain | Sep 29, 2026 |
| UBS | Buy | Buy | Maintain | Sep 24, 2026 |
| Truist Securities | Buy | Buy | Maintain | Sep 24, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Sep 24, 2026 |
| Baird | Outperform | Outperform | Maintain | Sep 24, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 16, 2026 |
| B of A Securities | Buy | Neutral | Upgrade | Jul 16, 2026 |
| Stifel | Hold | Hold | Maintain | Mar 26, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Dec 17, 2025 |
| JP Morgan | Overweight | Overweight | Maintain | Sep 25, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 2, 2025 |
| Barclays | Overweight | Overweight | Maintain | Sep 27, 2024 |
| Jefferies | Hold | Hold | Maintain | Sep 26, 2024 |
| CFRA | Sell | Strong Sell | Maintain | Sep 12, 2024 |
| Oppenheimer | Perform | Perform | Maintain | Apr 1, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 28, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Jul 16, 2021 |
| William Blair | Market Perform | Outperform | Downgrade | Apr 6, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Sep 25, 2019 |
| Nomura | Neutral | Neutral | Maintain | Jul 22, 2019 |
| Bank of America | Buy | Neutral | Upgrade | Jan 3, 2019 |
| Nomura Instinet | Neutral | Buy | Downgrade | Jun 27, 2017 |
| Instinet | Neutral | Buy | Downgrade | Jun 27, 2017 |
| KeyBanc | Overweight | Overweight | Maintain | Oct 3, 2016 |
| Macquarie | Neutral | Neutral | Maintain | Aug 25, 2016 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Mar 22, 2016 |
| PiperJaffray | Neutral | Neutral | Maintain | Nov 18, 2013 |
| Barrington Research | Market Perform | Outperform | Downgrade | Jul 17, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $214.9. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Argus Research | Analyst unavailable | $240 | $196.85 | +11.7% | Sep 29, 2026 |
| Robert W. Baird | Analyst unavailable | $222 | $191.97 | +3.3% | Sep 24, 2026 |
| UBS | Analyst unavailable | $230 | $203.66 | +7.0% | Jul 16, 2026 |
| Robert W. Baird | Analyst unavailable | $214 | $192.37 | -0.4% | Jul 16, 2026 |
| Wells Fargo | Analyst unavailable | $250 | $192.37 | +16.3% | Jul 16, 2026 |
| Goldman Sachs | Analyst unavailable | $231 | $192.37 | +7.5% | Jul 15, 2026 |
| UBS | Analyst unavailable | $228 | $168.85 | +6.1% | Mar 26, 2026 |
| Robert W. Baird | Andrew Wittmann | $250 | $198.34 | +16.3% | Mar 11, 2026 |
| Wells Fargo | Analyst unavailable | $245 | $192.72 | +14.0% | Jan 14, 2026 |
| UBS | Analyst unavailable | $235 | $188.31 | +9.4% | Dec 19, 2025 |
| Robert W. Baird | Analyst unavailable | $225 | $189.89 | +4.7% | Dec 19, 2025 |
| Wells Fargo | Analyst unavailable | $205 | $189.89 | -4.6% | Dec 19, 2025 |
| Morgan Stanley | Analyst unavailable | $210 | $188.45 | -2.3% | Dec 17, 2025 |
| Wells Fargo | Jason Haas | $185 | $182.16 | -13.9% | Nov 25, 2025 |
| Redburn Partners | Oliver Davies | $184 | $185.25 | -14.4% | Nov 11, 2025 |
| RBC Capital | Analyst unavailable | $206 | $202.05 | -4.1% | Sep 25, 2025 |
| Wells Fargo | Analyst unavailable | $218 | $202.05 | +1.4% | Sep 25, 2025 |
| Robert W. Baird | Analyst unavailable | $227 | $206.25 | +5.6% | Mar 27, 2025 |
| Truist Financial | Analyst unavailable | $230 | $204.71 | +7.0% | Mar 26, 2025 |
| Wells Fargo | Jason Haas | $184 | $183.03 | -14.4% | Dec 20, 2024 |
| Morgan Stanley | Toni Kaplan | $202 | $211.59 | -6.0% | Dec 12, 2024 |
| UBS | Joshua Chan | $240 | $210.39 | +11.7% | Sep 26, 2024 |
| Goldman Sachs | George Tong | $212 | $208.84 | -1.3% | Sep 25, 2024 |
| RBC Capital | Ashish Sabadra | $181 | $208.71 | -15.8% | Sep 25, 2024 |
| Barclays | Manav Patnaik | $210 | $204.23 | -2.3% | Sep 24, 2024 |
| Truist Financial | Jasper Bibb | $225 | $203.77 | +4.7% | Sep 17, 2024 |
| CFRA | Caydee Blankenship | $170 | $203.8 | -20.9% | Sep 11, 2024 |
| Wells Fargo | Jason Haas | $183.75 | $189.91 | -14.5% | Aug 12, 2024 |
| Redburn Partners | Oliver Davies | $167.5 | $187.61 | -22.1% | Aug 9, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $199.5 | $189.64 | -7.2% | Jul 19, 2024 |
| Robert W. Baird | Andrew Wittmann | $193.75 | $190.73 | -9.8% | Jul 19, 2024 |
| RBC Capital | Ashish Sabadra | $181.25 | $171.76 | -15.7% | Mar 28, 2024 |
| Robert W. Baird | Andrew Wittmann | $197.5 | $171.16 | -8.1% | Mar 28, 2024 |
| Truist Financial | Jasper Bibb | $193.75 | $170.51 | -9.8% | Mar 28, 2024 |
| UBS | Joshua Chan | $197.5 | $171.41 | -8.1% | Mar 28, 2024 |
| Robert W. Baird | Andrew Wittmann | $187.5 | $171.41 | -12.8% | Mar 28, 2024 |
| Truist Financial | Analyst unavailable | $193.75 | $171.41 | -9.8% | Mar 27, 2024 |
| J.P. Morgan | Andrew Steinerman | $160 | $158.67 | -25.5% | Mar 26, 2024 |
| Truist Financial | Jasper Bibb | $156.25 | $133.98 | -27.3% | Nov 13, 2023 |
| Argus Research | John Eade | $135 | $126.38 | -37.2% | Sep 26, 2023 |
| Morgan Stanley | Toni Kaplan | $32.69 | $29.03 | -84.8% | Mar 30, 2023 |
| Goldman Sachs | George Tong | $33.13 | $29.03 | -84.6% | Dec 21, 2022 |
| Morgan Stanley | Analyst unavailable | $23.31 | $24.26 | -89.2% | Sep 29, 2022 |
| Stifel Nicolaus | Shlomo Rosenbaum | $27.19 | $24.71 | -87.3% | Sep 28, 2022 |
| Morgan Stanley | Analyst unavailable | $22 | $24.3 | -89.8% | Sep 27, 2022 |
| Robert W. Baird | Analyst unavailable | $29.69 | $27.36 | -86.2% | Aug 17, 2022 |
| Morgan Stanley | Toni Kaplan | $22.63 | $24.18 | -89.5% | Jul 15, 2022 |
| Morgan Stanley | Analyst unavailable | $22.63 | $24.39 | -89.5% | Jul 15, 2022 |
| Deutsche Bank | Analyst unavailable | $29.06 | $23.05 | -86.5% | Jul 5, 2022 |
| Morgan Stanley | Analyst unavailable | $22.31 | $23.55 | -89.6% | May 26, 2022 |
| Deutsche Bank | Faiza Alwy | $129.25 | $105.97 | -39.9% | Apr 3, 2022 |
| Goldman Sachs | George Tong | $28.75 | $27.19 | -86.6% | Dec 23, 2021 |
| RBC Capital | Ashish Sabadra | $29.69 | $26.39 | -86.2% | Nov 30, 2021 |
| Stifel Nicolaus | Shlomo Rosenbaum | $23.63 | $24.09 | -89.0% | Oct 1, 2021 |
| Jefferies | Hamzah Mazari | $28 | $24.22 | -87.0% | Sep 29, 2021 |
| Credit Suisse | Kevin Mcveigh | $23.44 | $23.97 | -89.1% | Jul 16, 2021 |
Track every rating change on CTAS the moment it posts. Free to start.
Start freeGet the CTAS recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.